CUE
Cue Biopharma Inc
Price:  
0.90 
USD
Volume:  
493,138.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CUE EV/EBITDA

-1084.9%
Upside

As of 2025-07-19, the EV/EBITDA ratio of Cue Biopharma Inc (CUE) is -1.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CUE's latest enterprise value is 58.05 mil USD. CUE's TTM EBITDA according to its financial statements is -40.82 mil USD. Dividing these 2 quantities gives us the above CUE EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.8x - 13.1x 12.7x
Forward P/E multiples 17.0x - 31.9x 20.5x
Fair Price (9.09) - (6.95) (8.86)
Upside -1110.2% - -871.8% -1084.9%
0.90 USD
Stock Price
(8.86) USD
Fair Price

CUE EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-16 -1.34
2025-07-15 -1.05
2025-07-14 -1.20
2025-07-11 -1.17
2025-07-10 -1.23
2025-07-09 -1.21
2025-07-08 -1.11
2025-07-07 -1.05
2025-07-03 -1.04
2025-07-02 -1.04
2025-07-01 -1.00
2025-06-30 -1.02
2025-06-27 -1.13
2025-06-26 -1.22
2025-06-25 -1.21
2025-06-24 -1.10
2025-06-23 -0.97
2025-06-20 -1.05
2025-06-18 -0.97
2025-06-17 -0.83
2025-06-16 -0.85
2025-06-13 -0.87
2025-06-12 -0.93
2025-06-11 -0.94
2025-06-10 -0.93
2025-06-09 -0.94
2025-06-06 -0.94
2025-06-05 -0.92
2025-06-04 -0.91
2025-06-03 -0.93
2025-06-02 -0.97
2025-05-30 -0.94
2025-05-29 -0.95
2025-05-28 -0.92
2025-05-27 -0.98
2025-05-23 -0.98
2025-05-22 -1.07
2025-05-21 -0.87
2025-05-20 -1.00
2025-05-19 -1.07
2025-05-16 -1.10
2025-05-15 -1.10
2025-05-14 -1.14
2025-05-13 -1.18
2025-05-12 -1.15
2025-05-09 -1.20
2025-05-08 -1.18
2025-05-07 -1.18
2025-05-06 -1.15
2025-05-05 -1.20